The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hematology Diagnostics-Global Market Insights and Sales Trends 2024
Synopsis
Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets.
The global Hematology Diagnostics market size is expected to reach US$ 2730.1 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hematology Diagnostics in various end use industries. The expanding demands from the Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes and Others, are propelling Hematology Diagnostics market. Hematology Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hematology Consumables segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hematology Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hematology Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hematology Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hematology Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hematology Diagnostics covered in this report include Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche and Beckman Coulter, etc.
The global Hematology Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Sysmex Corporation
F. Hoffmann-La Roche
Beckman Coulter
Global Hematology Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematology Diagnostics market, Segment by Type:
Hematology Instruments
Hematology Consumables
Global Hematology Diagnostics market, by Application
Diagnostic Laboratories
Hospitals & Clinics
Academic Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hematology Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hematology Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hematology is defined as the diagnostic classification of cells present in the blood and resulting identification of diseases of the blood-forming organs and diseases of the blood. It includes the calculation of WBC, RBC, and platelets.
The global Hematology Diagnostics market size is expected to reach US$ 2730.1 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Hematology Diagnostics in various end use industries. The expanding demands from the Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes and Others, are propelling Hematology Diagnostics market. Hematology Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Hematology Consumables segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hematology Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hematology Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hematology Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hematology Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hematology Diagnostics covered in this report include Abbott Laboratories, Sysmex Corporation, F. Hoffmann-La Roche and Beckman Coulter, etc.
The global Hematology Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Sysmex Corporation
F. Hoffmann-La Roche
Beckman Coulter
Global Hematology Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hematology Diagnostics market, Segment by Type:
Hematology Instruments
Hematology Consumables
Global Hematology Diagnostics market, by Application
Diagnostic Laboratories
Hospitals & Clinics
Academic Institutes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hematology Diagnostics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hematology Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hematology Diagnostics Market Overview
1.1 Hematology Diagnostics Product Overview
1.2 Hematology Diagnostics Market Segment by Type
1.2.1 Hematology Instruments
1.2.2 Hematology Consumables
1.3 Global Hematology Diagnostics Market Size by Type
1.3.1 Global Hematology Diagnostics Market Size Overview by Type (2018-2029)
1.3.2 Global Hematology Diagnostics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hematology Diagnostics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hematology Diagnostics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hematology Diagnostics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hematology Diagnostics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hematology Diagnostics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hematology Diagnostics Sales Breakdown by Type (2018-2023)
2 Global Hematology Diagnostics Market Competition by Company
2.1 Global Top Players by Hematology Diagnostics Sales (2018-2023)
2.2 Global Top Players by Hematology Diagnostics Revenue (2018-2023)
2.3 Global Top Players by Hematology Diagnostics Price (2018-2023)
2.4 Global Top Manufacturers Hematology Diagnostics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hematology Diagnostics Market Competitive Situation and Trends
2.5.1 Hematology Diagnostics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hematology Diagnostics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hematology Diagnostics as of 2022)
2.7 Date of Key Manufacturers Enter into Hematology Diagnostics Market
2.8 Key Manufacturers Hematology Diagnostics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hematology Diagnostics Status and Outlook by Region
3.1 Global Hematology Diagnostics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hematology Diagnostics Historic Market Size by Region
3.2.1 Global Hematology Diagnostics Sales in Volume by Region (2018-2023)
3.2.2 Global Hematology Diagnostics Sales in Value by Region (2018-2023)
3.2.3 Global Hematology Diagnostics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hematology Diagnostics Forecasted Market Size by Region
3.3.1 Global Hematology Diagnostics Sales in Volume by Region (2024-2029)
3.3.2 Global Hematology Diagnostics Sales in Value by Region (2024-2029)
3.3.3 Global Hematology Diagnostics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hematology Diagnostics by Application
4.1 Hematology Diagnostics Market Segment by Application
4.1.1 Diagnostic Laboratories
4.1.2 Hospitals & Clinics
4.1.3 Academic Institutes
4.1.4 Others
4.2 Global Hematology Diagnostics Market Size by Application
4.2.1 Global Hematology Diagnostics Market Size Overview by Application (2018-2029)
4.2.2 Global Hematology Diagnostics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hematology Diagnostics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hematology Diagnostics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hematology Diagnostics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hematology Diagnostics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hematology Diagnostics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hematology Diagnostics Sales Breakdown by Application (2018-2023)
5 North America Hematology Diagnostics by Country
5.1 North America Hematology Diagnostics Historic Market Size by Country
5.1.1 North America Hematology Diagnostics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hematology Diagnostics Sales in Volume by Country (2018-2023)
5.1.3 North America Hematology Diagnostics Sales in Value by Country (2018-2023)
5.2 North America Hematology Diagnostics Forecasted Market Size by Country
5.2.1 North America Hematology Diagnostics Sales in Volume by Country (2024-2029)
5.2.2 North America Hematology Diagnostics Sales in Value by Country (2024-2029)
6 Europe Hematology Diagnostics by Country
6.1 Europe Hematology Diagnostics Historic Market Size by Country
6.1.1 Europe Hematology Diagnostics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hematology Diagnostics Sales in Volume by Country (2018-2023)
6.1.3 Europe Hematology Diagnostics Sales in Value by Country (2018-2023)
6.2 Europe Hematology Diagnostics Forecasted Market Size by Country
6.2.1 Europe Hematology Diagnostics Sales in Volume by Country (2024-2029)
6.2.2 Europe Hematology Diagnostics Sales in Value by Country (2024-2029)
7 Asia-Pacific Hematology Diagnostics by Region
7.1 Asia-Pacific Hematology Diagnostics Historic Market Size by Region
7.1.1 Asia-Pacific Hematology Diagnostics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hematology Diagnostics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hematology Diagnostics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hematology Diagnostics Forecasted Market Size by Region
7.2.1 Asia-Pacific Hematology Diagnostics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hematology Diagnostics Sales in Value by Region (2024-2029)
8 Latin America Hematology Diagnostics by Country
8.1 Latin America Hematology Diagnostics Historic Market Size by Country
8.1.1 Latin America Hematology Diagnostics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hematology Diagnostics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hematology Diagnostics Sales in Value by Country (2018-2023)
8.2 Latin America Hematology Diagnostics Forecasted Market Size by Country
8.2.1 Latin America Hematology Diagnostics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hematology Diagnostics Sales in Value by Country (2024-2029)
9 Middle East and Africa Hematology Diagnostics by Country
9.1 Middle East and Africa Hematology Diagnostics Historic Market Size by Country
9.1.1 Middle East and Africa Hematology Diagnostics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hematology Diagnostics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hematology Diagnostics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hematology Diagnostics Forecasted Market Size by Country
9.2.1 Middle East and Africa Hematology Diagnostics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hematology Diagnostics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Hematology Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Hematology Diagnostics Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Sysmex Corporation
10.2.1 Sysmex Corporation Company Information
10.2.2 Sysmex Corporation Introduction and Business Overview
10.2.3 Sysmex Corporation Hematology Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sysmex Corporation Hematology Diagnostics Products Offered
10.2.5 Sysmex Corporation Recent Development
10.3 F. Hoffmann-La Roche
10.3.1 F. Hoffmann-La Roche Company Information
10.3.2 F. Hoffmann-La Roche Introduction and Business Overview
10.3.3 F. Hoffmann-La Roche Hematology Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 F. Hoffmann-La Roche Hematology Diagnostics Products Offered
10.3.5 F. Hoffmann-La Roche Recent Development
10.4 Beckman Coulter
10.4.1 Beckman Coulter Company Information
10.4.2 Beckman Coulter Introduction and Business Overview
10.4.3 Beckman Coulter Hematology Diagnostics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Beckman Coulter Hematology Diagnostics Products Offered
10.4.5 Beckman Coulter Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hematology Diagnostics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hematology Diagnostics Industrial Chain Analysis
11.4 Hematology Diagnostics Market Dynamics
11.4.1 Hematology Diagnostics Industry Trends
11.4.2 Hematology Diagnostics Market Drivers
11.4.3 Hematology Diagnostics Market Challenges
11.4.4 Hematology Diagnostics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hematology Diagnostics Distributors
12.3 Hematology Diagnostics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
